Preview Mode Links will not work in preview mode

Feb 24, 2021

Featuring an interview with Dr Erika Hamilton on the following topics:

  • Management of ER-positive metastatic breast cancer (0:00)
  • Case: A woman in her early 60s with de novo ER-positive metastatic breast cancer develops a rash while receiving a PI3K inhibitor (24:08)
  • Case: A woman in her early 60s receives an oral SERD...


Feb 22, 2021

Featuring an interview with Dr Kathleen Moore on the following topics:

  • Recent data with PARP inhibitors and immune checkpoint inhibitors for advanced ovarian cancer (0:00)
  • Efficacy of lenvatinib alone and in combination with pembrolizumab in patients with previously treated ovarian cancer (34:23)
  • Activity of...


Feb 20, 2021

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Hematologic Cancers — Multiple Myeloma — Faculty Presentation 1: Consolidation and Maintenance Therapy in Newly Diagnosed MM — Role of MRD Testing — Dr Fonseca.
CME information and...


Feb 20, 2021

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Hematologic Cancers — Multiple Myeloma — Faculty Presentation 2: Other Novel Strategies with Potential to Improve Outcomes in MM — Dr Landgren.
CME information and select publications


Feb 20, 2021

Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Hematologic Cancers — Multiple Myeloma — Faculty Presentation 3: Selection and Sequencing of Available and Recently Approved Therapies for Patients with Relapsed/Refractory MM —...